This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Ciaran O'Reilly: Innovator in Pharmaceutical Research
Introduction
Ciaran O'Reilly is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Ciaran O'Reilly holds a patent for Nicotinamide RIPK1 inhibitors. This patent includes compounds of Formula (I) and pharmaceutically acceptable salts that are useful as RIPK1 inhibitors. The patent also details pharmaceutical compositions comprising these compounds, as well as methods of use and preparation. Additionally, it provides methods for treating Ulcerative Colitis using a compound of Formula (I).
Career Highlights
Ciaran O'Reilly is currently employed at AbbVie Inc., a global biopharmaceutical company. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in treatment options for various medical conditions.
Collaborations
Ciaran collaborates with talented colleagues, including Hannah Dexter and Euan Fordyce. Their combined expertise enhances the research and development efforts within their team.
Conclusion
Ciaran O'Reilly's work in pharmaceutical research, particularly with his patent on Nicotinamide RIPK1 inhibitors, showcases his commitment to advancing medical science. His contributions are vital in the ongoing quest for effective treatments for diseases like Ulcerative Colitis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile